GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹1,421 Cr | ₹1,075 Cr | ₹1,219 Cr | ₹908 Cr | ₹972 Cr |
What is the latest Short Term Loans and Advances ratio of GLENMARK PHARMACEUTICALS ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2026 | ₹1,421 Cr |
| Mar2025 | ₹1,075 Cr |
| Mar2024 | ₹1,219 Cr |
| Mar2023 | ₹908 Cr |
| Mar2022 | ₹972 Cr |
How is Short Term Loans and Advances of GLENMARK PHARMACEUTICALS Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,421 Cr | 32.20 | |
| Mar2025 | ₹1,075 Cr | -11.83 | |
| Mar2024 | ₹1,219 Cr | 34.26 | |
| Mar2023 | ₹908 Cr | -6.63 | |
| Mar2022 | ₹972 Cr | - | |
Compare Short Term Loans and Advances of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,915.9 Cr | 5.4% | -3.5% | 22.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 5.4% |
-3.5% |
22.3% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses